Overview

A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
To explore the effect of CP-690,550 on blood and synovial markers in subjects with rheumatoid arthritis. To evaluate the safety, tolerability and efficacy of CP-690,550.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Methotrexate
Tofacitinib